Heron Therapeutics | HRTX - Dividend Yield


Heron Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Anika Therapeutics 0 0 Mar/2025
Eisai 3.22 0.64 Sep/2025
Emergent BioSolutions 0 0 Mar/2025
Esperion Therapeutics 0 0 Mar/2025
GlaxoSmithKline 4.57 1.52 Dec/2025
Heron Therapeutics 0 0 Mar/2025
Merck 3.12 0.74 Dec/2025
Nektar Therapeutics 0 0 Mar/2025
Omeros 0 0 Mar/2025
Regeneron Pharmaceuticals 0.46 0.01 Dec/2025
Roche Holding 2.96 0.8 Dec/2025
Sangamo BioSciences 0 0 Mar/2025
Surmodics 0 0 Mar/2025